{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:33:56Z","timestamp":1762900436866,"version":"3.45.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T00:00:00Z","timestamp":1701734400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.eclinm.2023.102389","type":"journal-article","created":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T07:51:40Z","timestamp":1703231500000},"page":"102389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Prospective observational studies to provide confidence in the protection conferred by newer generation, inactivated oral cholera vaccines: a proposal"],"prefix":"10.1016","volume":"67","author":[{"given":"John","family":"Clemens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Deen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Firdausi","family":"Qadri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.eclinm.2023.102389_bib1","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S1473-3099(17)30359-6","article-title":"Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis","volume":"17","author":"Bi","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.eclinm.2023.102389_bib2","doi-asserted-by":"crossref","first-page":"A132","DOI":"10.1016\/j.vaccine.2019.08.086","article-title":"Oral Cholera Vaccine Working Group of the Global Task Force on Cholera C. Global oral cholera vaccine use, 2013-2018","volume":"38","author":"Pezzoli","year":"2020","journal-title":"Vaccine"},{"year":"2023","series-title":"Cholera \u2013 global situation","key":"10.1016\/j.eclinm.2023.102389_bib3"},{"issue":"32","key":"10.1016\/j.eclinm.2023.102389_bib4","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1016\/j.vaccine.2021.06.069","article-title":"A\u00a0phase I\/II study to evaluate safety, tolerability and immunogenicity of Hillchol(R), an inactivated single Hikojima strain based oral cholera vaccine, in a sequentially age descending population in Bangladesh","volume":"39","author":"Chowdhury","year":"2021","journal-title":"Vaccine"},{"author":"Eubiologics","key":"10.1016\/j.eclinm.2023.102389_bib5"},{"issue":"10","key":"10.1016\/j.eclinm.2023.102389_bib6","doi-asserted-by":"crossref","first-page":"e292","DOI":"10.1016\/S1473-3099(22)00215-8","article-title":"Evaluating improved inactivated oral cholera vaccines for use in ending endemic cholera by 2030: opportunities and challenges","volume":"22","author":"Deen","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"25","key":"10.1016\/j.eclinm.2023.102389_bib7","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJM200006223422507","article-title":"Randomized, controlled trials, observational studies, and the hierarchy of research designs","volume":"342","author":"Concato","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.eclinm.2023.102389_bib8","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.eclinm.2023.102389_bib9","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/0002-9343(90)90182-D","article-title":"Developing improved observational methods for evaluating therapeutic effectiveness","volume":"89","author":"Horwitz","year":"1990","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.eclinm.2023.102389_bib11","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/jpids\/piu058","article-title":"Case-control studies to assess the effectiveness of vaccines","volume":"3","author":"Shapiro","year":"2014","journal-title":"J\u00a0Pediatr Infect Dis Soc"},{"issue":"8","key":"10.1016\/j.eclinm.2023.102389_bib12","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJMoa043323","article-title":"Effectiveness of mass oral cholera vaccination in Beira, Mozambique","volume":"352","author":"Lucas","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"22","key":"10.1016\/j.eclinm.2023.102389_bib13","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1056\/NEJMoa1312680","article-title":"Use of Vibrio cholerae vaccine in an outbreak in Guinea","volume":"370","author":"Luquero","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.eclinm.2023.102389_bib14","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.1016\/S2214-109X(14)70368-7","article-title":"Effectiveness of reactive oral cholera vaccination in rural Haiti: a case-control study and bias-indicator analysis","volume":"3","author":"Ivers","year":"2015","journal-title":"Lancet Glob Health"},{"issue":"4","key":"10.1016\/j.eclinm.2023.102389_bib15","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.vaccine.2015.12.004","article-title":"Validity of the estimates of oral cholera vaccine effectiveness derived from the test-negative design","volume":"34","author":"Ali","year":"2016","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.eclinm.2023.102389_bib16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/14760584.2017.1291348","article-title":"PaxVax CVD 103-HgR single-dose live oral cholera vaccine","volume":"16","author":"Levine","year":"2017","journal-title":"Expert Rev Vaccines"},{"issue":"22","key":"10.1016\/j.eclinm.2023.102389_bib17","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/S0264-410X(00)00006-2","article-title":"Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area","volume":"18","author":"Richie","year":"2000","journal-title":"Vaccine"},{"issue":"30","key":"10.1016\/j.eclinm.2023.102389_bib18","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1016\/j.vaccine.2021.05.099","article-title":"Evaluation of post-introduction COVID-19 vaccine effectiveness: summary of interim guidance of the World Health Organization","volume":"39","author":"Patel","year":"2021","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.eclinm.2023.102389_bib19","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1016\/j.vaccine.2015.03.073","article-title":"Effectiveness of an oral cholera vaccine campaign to prevent clinically-significant cholera in Odisha State, India","volume":"33","author":"Wierzba","year":"2015","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.eclinm.2023.102389_bib20","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S1473-3099(12)70196-2","article-title":"Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study","volume":"12","author":"Khatib","year":"2012","journal-title":"Lancet Infect Dis"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537023005667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537023005667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:22:11Z","timestamp":1762899731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537023005667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":19,"alternative-id":["S2589537023005667"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2023.102389","relation":{},"ISSN":["2589-5370"],"issn-type":[{"type":"print","value":"2589-5370"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective observational studies to provide confidence in the protection conferred by newer generation, inactivated oral cholera vaccines: a proposal","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2023.102389","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102389"}}